Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC

Jane Street Group LLC decreased its holdings in Immutep Limited (NASDAQ:IMMP) by 35.9% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 80,489 shares of the biotechnology company’s stock after selling 45,093 shares during the quarter. Jane Street Group LLC owned approximately 0.06% of Immutep worth $178,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the business. XTX Topco Ltd acquired a new position in shares of Immutep in the second quarter worth about $26,000. Meridian Wealth Management LLC lifted its stake in shares of Immutep by 4.5% in the third quarter. Meridian Wealth Management LLC now owns 398,450 shares of the biotechnology company’s stock worth $881,000 after acquiring an additional 17,250 shares in the last quarter. Finally, XY Capital Ltd lifted its stake in shares of Immutep by 108.3% in the third quarter. XY Capital Ltd now owns 108,349 shares of the biotechnology company’s stock worth $239,000 after acquiring an additional 56,344 shares in the last quarter. Institutional investors and hedge funds own 2.32% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Robert W. Baird boosted their price target on Immutep from $6.00 to $7.00 and gave the stock an “outperform” rating in a research note on Friday, November 15th.

Immutep Trading Down 3.5 %

Shares of NASDAQ IMMP opened at $1.94 on Tuesday. The stock’s 50 day moving average price is $2.03 and its two-hundred day moving average price is $2.10. Immutep Limited has a 52-week low of $1.66 and a 52-week high of $3.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 18.25 and a current ratio of 18.25.

About Immutep

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.